Analyst Ratings for Akari Therapeutics (AKTX)
AKTX Rating Summary
AKTX Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$1.30 (-88.2%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
Avg. $ Target:
$1.30 (-88.2%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/8/2026 | Maxim Group | Jason McCarthy | Downgrade | Hold (Buy) |
N/A (N/A) |
3.80 (11.01) |
189.74% | Details |
| 1/5/2026 | Ladenburg Thalmann | Aydi | New Coverage | Buy (N/A) |
1.00 (N/A) |
0.29 (11.01) |
3696.55% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
